(1) Department of Oncology, Aberdeen Royal Infirmary, Foresterhill, Aberdeen, AB25 2ZN, UK;(2) Department of Radiation Oncology, University Hospital of Larissa, Larissa, Greece
Abstract:
Background
Hypofractionated adjuvant radiotherapy (RT) in breast cancer patients treated by conservative surgery has been increasingly used in recent years. We present our experience regarding tolerance/acute toxicity of a hypofractionated RT schedule.